Navigation Links
Beactica Announces Drug Discovery Collaboration With Arrow Therapeutics
Date:11/12/2007

UPPSALA, Sweden, November 12 /PRNewswire/ -- Beactica AB announced today that it has entered into a drug discovery collaboration agreement with Arrow Therapeutics Ltd (London, UK) whereby Beactica will direct its novel characterisation technology at selected Arrow compounds against a confidential target.

(Logo: http://www.newscom.com/cgi-bin/prnh/20071112/281137 )

"We are very pleased to be working with Arrow" said Beactica's CEO, Dr Per Kallblad. "The company has a world-class reputation for conducting break through research in the antiviral field and we look forward to applying our technology on their targets."

CEO of Arrow Therapeutics, Dr Ken Powell, said "Working with Beactica provides us with an opportunity to apply a new technology that has already shown strong potential."

About Beactica

Beactica AB is a specialist drug discovery company, utilising its proprietary methodologies to evaluate the biophysical interaction of molecules in order to generate novel therapeutics. As well as building collaborations with external companies, Beactica is progressing its own drug discovery programmes.

For more information about Beactica, please visit http://www.beactica.com.

About Arrow Therapeutics

Arrow Therapeutics Ltd is a fully integrated pharmaceutical company, focused exclusively on the discovery and development of novel antiviral therapeutics in areas of significant unmet need. Established in 1998 and acquired by AstraZeneca in February 2007, Arrow specialises in small molecule drugs with novel mechanisms of action. The company has a number of research and development programs, the most advanced of which target Respiratory Syncytial Virus (RSV) and Hepatitis C Virus (HCV).

For more information about Arrow Therapeutics, please visit

SOURCE Beactica AB
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
2. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
3. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
4. HEI, Inc. Announces Sale of RFID Division Assets
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
8. Brooke Franchise Corporation Announces Selected July Results
9. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
11. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Warner Chilcott Considers Potential Repurchase or Redemption of 8.75% Senior Subordinated Notes 2Warner Chilcott Considers Potential Repurchase or Redemption of 8.75% Senior Subordinated Notes 3Warner Chilcott Considers Potential Repurchase or Redemption of 8.75% Senior Subordinated Notes 4Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customer's Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders 2Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customer's Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders 3Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customer's Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders 4Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy 2Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy 3Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy 4University of Toronto study shows disparity of effect of climate change on UV radiation 9934 1University of Toronto study shows disparity of effect of climate change on UV radiation 9934 2University of Miami receives NIH grant to support novel technology for tissue engineering 9930 1University of Miami receives NIH grant to support novel technology for tissue engineering 9930 2Seniors Launch Campaign to Have a Fair Say on Health Care Reform 57210 1Seniors Launch Campaign to Have a Fair Say on Health Care Reform 57210 2